Emerald Health Therapeutics, Inc. EMHTF OTC

Emerald Health Therapeutics, Inc. (EMHTF) reported total assets of $33.91M and total liabilities of $6.07M for quarter ending 2022-06-30, resulting in total equity of $27.84M.

The company held $15.52M in cash and short-term investments. Total debt stood at $260K, with net debt of $-15.26M. The Debt-to-Equity (D/E) ratio was 0.01 (conservative).

Current ratio is 2.98, indicating strong short-term liquidity. Interest coverage is -1.1x (weak).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (15/100) — Total assets $33.91M and equity $27.84M support the company's competitive scale

Overall SharesGrow Score: 28/100 with 0/7 criteria passed.